$DGX
QUEST DIAGNOSTICS INC Stock $dgx

$dgx Overview Financials Valuation SEC Filings Company Website

2012 Q4 Form 10-Q Financial Statement

#000102207912000032 Filed on October 24, 2012

Income Statement

Concept	2012 Q4	2012 Q3	2011 Q3
Revenue	$1.774B	$1.822B	$1.875B
YoY Change	-4.02%	-2.83%	0.56%
Cost Of Revenue	$1.090B	$1.081B	$1.117B
YoY Change	1.14%	-3.18%	2.3%
Gross Profit	$701.0M	$741.0M	$767.7M
YoY Change	-10.06%	-3.48%	-0.71%
Gross Profit Margin	39.52%	40.67%	40.95%
Selling, General & Admin	$396.8M	$416.9M	$446.6M
YoY Change	-10.45%	-6.66%	4.69%
% of Gross Profit	56.6%	56.26%	58.17%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$71.30M	$51.31M	$53.95M
YoY Change	-0.56%	-4.88%	-15.84%
% of Gross Profit	10.17%	6.92%	7.03%
Operating Expenses	$412.0M	$416.9M	$446.6M
YoY Change	-10.96%	-6.66%	2.36%
Operating Profit	$289.0M	$304.6M	$322.1M
YoY Change	-8.75%	-5.41%	-4.4%
Interest Expense	-$34.00M	$41.69M	$44.06M
YoY Change	-7.1%	-5.39%	-251.93%
% of Operating Profit	-11.76%	13.68%	13.68%
Other Income/Expense, Net	$700.0K	-$33.65M	-$38.78M
YoY Change	-80.56%	-13.25%	-1312.0%
Pretax Income	$231.6M	$271.0M	$283.3M
YoY Change	-20.74%	-4.34%	-8.91%
Income Tax	$81.60M	$104.0M	$101.1M
% Of Pretax Income	35.23%	38.37%	35.7%
Net Earnings	$56.00M	$163.0M	$171.8M
YoY Change	-70.44%	-5.15%	-13.24%
Net Earnings / Revenue	3.16%	8.95%	9.17%
Basic Earnings Per Share	$0.35	$1.02	$1.08
Diluted Earnings Per Share	$0.34	$1.01	$1.07
COMMON SHARES
Basic Shares Outstanding	159.0M shares	158.8M shares	157.8M shares
Diluted Shares Outstanding		160.7M shares	159.0M shares

Balance Sheet

Concept	2012 Q4	2012 Q3	2011 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$296.0M	$192.0M	$111.0M
YoY Change	79.39%	72.97%	-69.92%
Cash & Equivalents	$296.0M	$191.8M	$110.8M
Short-Term Investments
Other Short-Term Assets	$305.0M	$255.0M	$264.0M
YoY Change	-7.55%	-3.41%	16.81%
Inventory	$93.00M	$94.51M	$85.00M
Prepaid Expenses
Receivables	$867.0M	$930.7M	$936.0M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.561B	$1.472B	$1.396B
YoY Change	11.4%	5.46%	-10.11%
LONG-TERM ASSETS
Property, Plant & Equipment	$756.0M	$782.8M	$806.0M
YoY Change	-5.47%	-2.88%	-0.74%
Goodwill	$5.536B	$5.837B
YoY Change	-4.49%
Intangibles	$872.0M	$1.003B
YoY Change	-15.8%
Long-Term Investments	$46.00M
YoY Change	2.18%
Other Assets	$205.0M	$223.9M	$273.0M
YoY Change	-27.04%	-17.97%	45.21%
Total Long-Term Assets	$7.723B	$7.846B	$7.930B
YoY Change	-2.39%	-1.05%	14.83%
TOTAL ASSETS
Total Short-Term Assets	$1.561B	$1.472B	$1.396B
Total Long-Term Assets	$7.723B	$7.846B	$7.930B
Total Assets	$9.284B	$9.319B	$9.326B
YoY Change	-0.32%	-0.08%	10.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.016B	$916.0M	$928.0M
YoY Change	12.02%	-1.29%	13.59%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$10.00M	$155.0M	$836.0M
YoY Change	-98.24%	-81.46%	151.81%
Total Short-Term Liabilities	$1.048B	$1.071B	$1.764B
YoY Change	-32.87%	-39.31%	53.66%
LONG-TERM LIABILITIES
Long-Term Debt	$3.354B	$3.376B	$3.368B
YoY Change	-0.5%	0.24%	18.76%
Other Long-Term Liabilities	$636.0M	$674.8M	$650.0M
YoY Change	-4.6%	3.81%	9.43%
Total Long-Term Liabilities	$636.0M	$674.8M	$4.018B
YoY Change	-4.6%	-83.21%	17.14%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.048B	$1.071B	$1.764B
Total Long-Term Liabilities	$636.0M	$674.8M	$4.018B
Total Liabilities	$1.684B	$1.745B	$5.804B
YoY Change	-24.41%	-69.93%	26.12%
SHAREHOLDERS EQUITY
Retained Earnings	$4.690B	$4.682B
YoY Change	10.0%
Common Stock	$2.373B	$2.364B
YoY Change	0.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$2.914B	$2.889B
YoY Change	0.06%
Treasury Stock Shares	57.00M shares	56.35M shares
Shareholders Equity	$4.163B	$4.171B	$3.522B
YoY Change
Total Liabilities & Shareholders Equity	$9.284B	$9.319B	$9.326B
YoY Change	-0.32%	-0.08%	10.25%

Cashflow Statement

Concept	2012 Q4	2012 Q3	2011 Q3
OPERATING ACTIVITIES
Net Income	$56.00M	$163.0M	$171.8M
YoY Change	-70.44%	-5.15%	-13.24%
Depreciation, Depletion And Amortization	$71.30M	$51.31M	$53.95M
YoY Change	-0.56%	-4.88%	-15.84%
Cash From Operating Activities	$363.1M	$394.7M	$337.6M
YoY Change	7.49%	16.91%	2.27%
INVESTING ACTIVITIES
Capital Expenditures	-$59.90M	-$44.90M	-$39.30M
YoY Change	37.07%	14.25%	-17.26%
Acquisitions		$6.000K	$162.1M
YoY Change		-100.0%
Other Investing Activities	$17.80M	$400.0K	-$154.9M
YoY Change	673.91%	-100.26%	51533.33%
Cash From Investing Activities	-$42.10M	-$44.50M	-$194.1M
YoY Change	1.94%	-77.07%	306.07%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-217.2M	-332.2M	-216.9M
YoY Change	-10.4%	53.16%	-39.9%
NET CHANGE
Cash From Operating Activities	363.1M	394.7M	337.6M
Cash From Investing Activities	-42.10M	-44.50M	-194.1M
Cash From Financing Activities	-217.2M	-332.2M	-216.9M
Net Change In Cash	103.8M	18.00M	-73.40M
YoY Change	91.87%	-124.52%	-6.62%
FREE CASH FLOW
Cash From Operating Activities	$363.1M	$394.7M	$337.6M
Capital Expenditures	-$59.90M	-$44.90M	-$39.30M
Free Cash Flow	$423.0M	$439.6M	$376.9M
YoY Change	10.88%	16.64%	-0.19%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.75
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.76
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	3.14
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1546000	shares
	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	630000	USD
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	USD
CY2011Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-8067000	USD
CY2012Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2361477000	USD
CY2011Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2347518000	USD
CY2012Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	191770000	USD
CY2011Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	906764000	USD
CY2012Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	915991000	USD
CY2012Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	930732000	USD
CY2011Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	906455000	USD
CY2012Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	13968000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	50789000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	43087000	USD
	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	4845000	USD
	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	6419000	USD
CY2012Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	233949000	USD
CY2011Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	237339000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	47843000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	60361000	USD
CY2011Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	19402000	USD
CY2012Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	19961000	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1925000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2213000	shares
CY2011Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2333000	shares
CY2012Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1317000	shares
CY2012Q3	us-gaap	Assets Assets	9318721000	USD
CY2011Q4	us-gaap	Assets Assets	9313379000	USD
CY2011Q4	us-gaap	Assets Current AssetsCurrent	1401260000	USD
CY2012Q3	us-gaap	Assets Current AssetsCurrent	1472265000	USD
CY2011Q4	us-gaap	Assets Fair Value Disclosure Recurring AssetsFairValueDisclosureRecurring	125208000	USD
CY2012Q3	us-gaap	Assets Fair Value Disclosure Recurring AssetsFairValueDisclosureRecurring	77794000	USD
CY2012Q3	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	USD
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	112312000	USD
CY2011Q3	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	164886000	USD
CY2011Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	110825000	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	449301000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	26884000	USD
CY2011Q3	us-gaap	Costs And Expenses CostsAndExpenses	1584352000	USD
CY2011Q4	us-gaap	Debt Current DebtCurrent	654395000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-338476000	USD
	us-gaap	Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths	1300000	USD
CY2011Q4	us-gaap	Cash Surrender Value Fair Value Disclosure CashSurrenderValueFairValueDisclosure	20936000	USD
CY2012Q3	us-gaap	Cash Surrender Value Fair Value Disclosure CashSurrenderValueFairValueDisclosure	24571000	USD
CY2012Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.17
CY2011Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.10
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.30
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.51
CY2012Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2011Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2011Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2012Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2012Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	215062000	shares
CY2011Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	214607000	shares
CY2011Q4	us-gaap	Common Stock Value CommonStockValue	2146000	USD
CY2012Q3	us-gaap	Common Stock Value CommonStockValue	2151000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	521940000	USD
CY2012Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	185419000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	265060000	USD
CY2011Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	132361000	USD
CY2011Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	10045000	USD
CY2012Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	8456000	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	25628000	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	26621000	USD
CY2011Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	142406000	USD
CY2012Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	193875000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	290688000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	548561000	USD
CY2012Q3	us-gaap	Cost Of Revenue CostOfRevenue	1089718000	USD
CY2011Q3	us-gaap	Cost Of Revenue CostOfRevenue	1116574000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	3317966000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	3316770000	USD
CY2012Q3	us-gaap	Costs And Expenses CostsAndExpenses	1542706000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	4961316000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	4751639000	USD
CY2012Q3	us-gaap	Debt Current DebtCurrent	154649000	USD
CY2012Q3	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	4100000000	USD
CY2011Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	4400000000	USD
CY2012Q3	us-gaap	Deferred Gain Loss On Discontinuation Of Interest Rate Fair Value Hedge DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge	65200000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	139000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	3255000	USD
CY2012Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.02
CY2011Q3	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	0.10
CY2012Q3	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	169006000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	153328000	USD
	us-gaap	Depreciation Depreciation	154939000	USD
CY2011Q3	us-gaap	Depreciation Depreciation	53945000	USD
CY2012Q3	us-gaap	Depreciation Depreciation	51310000	USD
	us-gaap	Depreciation Depreciation	161588000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	215300000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	209431000	USD
CY2012Q3	us-gaap	Derivative Assets Liabilities At Fair Value Net DerivativeAssetsLiabilitiesAtFairValueNet	266000	USD
CY2011Q4	us-gaap	Derivative Assets Liabilities At Fair Value Net DerivativeAssetsLiabilitiesAtFairValueNet	55052000	USD
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	1976000	USD
CY2011Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	188000	USD
CY2012Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	563000	USD
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	-93000	USD
CY2011Q3	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	438000	USD
CY2012Q3	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	524000	USD
	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	1718000	USD
	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	1038000	USD
	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	0	USD
	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	0	USD
CY2012Q3	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	0	USD
CY2011Q3	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	0	USD
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	47484000	USD
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	81239000	USD
CY2011Q4	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	0.17
CY2011Q1	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	0.10
CY2012Q1	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	0.17
CY2012Q3	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	0.17
CY2011Q2	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	0.10
CY2012Q2	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	0.17
CY2011Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.08
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.14
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.11
CY2012Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.74
CY2011Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.07
CY2011Q4	us-gaap	Equity Method Investments Fair Value Disclosure EquityMethodInvestmentsFairValueDisclosure	646000	USD
CY2012Q3	us-gaap	Equity Method Investments Fair Value Disclosure EquityMethodInvestmentsFairValueDisclosure	784000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	3810000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	4575000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	4575000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	3810000	USD
CY2012Q3	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	0	USD
CY2011Q3	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	4729000	USD
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	1560173000	USD
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	50800000	USD
CY2011Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	259245000	USD
CY2012Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	320912000	USD
CY2012Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	346261000	USD
CY2012Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	78643000	USD
CY2012Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	19954000	USD
CY2012Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	53635000	USD
CY2012Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	58215000	USD
CY2012Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	64925000	USD
CY2012Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	76287000	USD
CY2012Q3	us-gaap	Goodwill Goodwill	5837179000	USD
CY2011Q4	us-gaap	Goodwill Goodwill	5795765000	USD
CY2010Q4	us-gaap	Goodwill Goodwill	5101938000	USD
CY2011	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	701087000	USD
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	28144000	USD
CY2011Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	172098000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	499647000	USD
CY2012Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	163043000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	282261000	USD
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	526268000	USD
CY2012Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	171499000	USD
CY2011Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	182143000	USD
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	307889000	USD
CY2011Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.08
CY2012Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.02
CY2011Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.08
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.75
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	3.11
CY2012Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.01
CY2011Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-250000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	258000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-1131000	USD
CY2012Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	39000	USD
CY2011Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-250000	USD
CY2012Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	39000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-1131000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	258000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.00
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.01
CY2012Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.00
CY2011Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.00
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.01
CY2012Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.00
CY2011Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.01
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.00
CY2012Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	4662000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	22869000	USD
CY2011Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	7301000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	19643000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	317111000	USD
CY2012Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	103340000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	256114000	USD
CY2011Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	101126000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	292147000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	132655000	USD
CY2012Q3	us-gaap	Income Taxes Paid IncomeTaxesPaid	89338000	USD
CY2011Q3	us-gaap	Income Taxes Paid IncomeTaxesPaid	24934000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-56134000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-84408000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	122061000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	32311000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-10425000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-5881000	USD
CY2011Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1186000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1548000	shares
CY2011Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	3370522000	USD
CY2012Q3	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	3375727000	USD
CY2012Q3	us-gaap	Malpractice Loss Contingency Accrual Undiscounted MalpracticeLossContingencyAccrualUndiscounted	115000000	USD
CY2011Q4	us-gaap	Malpractice Loss Contingency Accrual Undiscounted MalpracticeLossContingencyAccrualUndiscounted	127000000	USD
CY2012Q3	us-gaap	Minority Interest MinorityInterest	26323000	USD
CY2011Q4	us-gaap	Minority Interest MinorityInterest	22127000	USD
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	24112000	USD
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	25765000	USD
CY2012Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1919000	shares
CY2011Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1035612000	USD
CY2012Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1002519000	USD
	us-gaap	Interest Expense InterestExpense	127311000	USD
CY2012Q3	us-gaap	Interest Expense InterestExpense	41685000	USD
CY2011Q3	us-gaap	Interest Expense InterestExpense	44059000	USD
	us-gaap	Interest Expense InterestExpense	129570000	USD
CY2012Q3	us-gaap	Interest Paid InterestPaid	47390000	USD
	us-gaap	Interest Paid InterestPaid	128301000	USD
	us-gaap	Interest Paid InterestPaid	129380000	USD
CY2011Q3	us-gaap	Interest Paid InterestPaid	55718000	USD
CY2012Q3	us-gaap	Inventory Net InventoryNet	94511000	USD
CY2011Q4	us-gaap	Inventory Net InventoryNet	89132000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1652000	USD
CY2012Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	657000	USD
CY2011Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	651000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	2008000	USD
CY2012Q3	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	60000000	USD
CY2012Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9318721000	USD
CY2011Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9313379000	USD
CY2012Q3	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	0	USD
	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	269000	USD
	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	148192000	USD
CY2011Q3	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	0	USD
CY2012Q3	us-gaap	Liabilities Current LiabilitiesCurrent	1070640000	USD
CY2011Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1561159000	USD
CY2011Q4	us-gaap	Liabilities Fair Value Disclosure Recurring LiabilitiesFairValueDisclosureRecurring	73336000	USD
CY2012Q3	us-gaap	Liabilities Fair Value Disclosure Recurring LiabilitiesFairValueDisclosureRecurring	81407000	USD
CY2012Q3	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	85000000	USD
CY2012Q3	us-gaap	Litigation Reserve LitigationReserve	5000000	USD
CY2011Q4	us-gaap	Litigation Reserve LitigationReserve	5000000	USD
CY2012Q3	us-gaap	Notional Amount Of Foreign Currency Derivatives NotionalAmountOfForeignCurrencyDerivatives	12300000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	943066000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	669867000	USD
CY2012Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	308733000	USD
CY2011Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	322053000	USD
CY2012Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-33894000	USD
	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DESCRIPTION OF BUSINESS</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">    </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Background</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">    </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Quest Diagnostics Incorporated and its subsidiaries ("Quest Diagnostics" or the "Company") is the world's leading provider of diagnostic testing, information and services, </font><font style="font-family:inherit;font-size:10pt;">providing insights that enable patients and physicians to make better healthcare decisions.</font><font style="font-family:inherit;font-size:10pt;"> Quest Diagnostics offers patients and physicians the broadest access to diagnostic laboratory services through the Company's nationwide network of laboratories and patient service centers. The Company provides interpretive consultation through the largest medical and scientific staff in the industry, with hundreds of M.D.s and Ph.D.s, primarily located in the United States. Quest Diagnostics is the leading provider of clinical testing, including gene-based and esoteric testing, and anatomic pathology services, and the leading provider of risk assessment services for the life insurance industry in North America. The Company is also a leading provider of testing for clinical trials and testing for drugs-of-abuse. The Company's diagnostics products business manufactures and markets diagnostic test kits and specialized point-of-care testing. Quest Diagnostics empowers healthcare organizations and clinicians with robust information technology solutions.</font></div></div>
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	305854000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-604881000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-174990000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1202058000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	806755000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	557728000	USD
CY2012Q3	us-gaap	Net Income Loss NetIncomeLoss	163082000	USD
	us-gaap	Net Income Loss NetIncomeLoss	499905000	USD
	us-gaap	Net Income Loss NetIncomeLoss	281130000	USD
CY2011Q3	us-gaap	Net Income Loss NetIncomeLoss	171848000	USD
CY2012Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	8456000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	25628000	USD
CY2011Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	10045000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	26621000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-105864000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-99687000	USD
CY2011Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-38784000	USD
CY2011Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	280971000	USD
CY2012Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	223946000	USD
CY2012Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-161000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	84000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-2173000	USD
CY2011Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-577000	USD
CY2012Q3	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	210000	USD
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	2658329000	USD
CY2012Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	86246000	USD
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	715000000	USD
	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-1252000	USD
CY2011Q3	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	209000	USD
CY2011Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-39119000	USD
CY2012Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	22288000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	21321000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-12645000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-16070000	USD
CY2011Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-39487000	USD
CY2012Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	22337000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	22035000	USD
CY2012Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	674773000	USD
CY2011Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	666699000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	5350000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-5732000	USD
CY2012Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2472000	USD
CY2011Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2677000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5973000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-815000	USD
	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	0	USD
	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	241000000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	2098000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-798000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	149996000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	884995000	USD
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	48830000	USD
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	81034000	USD
	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	24112000	USD
	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	25765000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	1298518000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	50574000	USD
CY2011Q3	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	162138000	USD
CY2012Q3	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	6000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	117879000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	122318000	USD
CY2011Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	87459000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-6402000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	9542000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities Equity ProceedsFromSaleOfAvailableForSaleSecuritiesEquity	0	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities Equity ProceedsFromSaleOfAvailableForSaleSecuritiesEquity	213541000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	143945000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	104004000	USD
CY2012Q3	us-gaap	Profit Loss ProfitLoss	171538000	USD
	us-gaap	Profit Loss ProfitLoss	526526000	USD
	us-gaap	Profit Loss ProfitLoss	306758000	USD
CY2011Q3	us-gaap	Profit Loss ProfitLoss	181893000	USD
CY2012Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	782812000	USD
CY2011Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	799771000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	208360000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	214373000	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	1495062000	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	1222036000	USD
CY2012Q3	us-gaap	Restructuring Reserve RestructuringReserve	26534000	USD
CY2011Q4	us-gaap	Restructuring Reserve RestructuringReserve	31964000	USD
	us-gaap	Restructuring Reserve Accrual Adjustment RestructuringReserveAccrualAdjustment	269000	USD
	us-gaap	Restructuring Reserve Settled With Cash RestructuringReserveSettledWithCash	5161000	USD
CY2012Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	4682265000	USD
CY2011Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	4263599000	USD
CY2012Q3	us-gaap	Sales Revenue Net SalesRevenueNet	1851439000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	5694705000	USD
CY2011Q3	us-gaap	Sales Revenue Net SalesRevenueNet	1906405000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	5631183000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1357242000	USD
CY2011Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	446595000	USD
CY2012Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	432627000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1374056000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	50789000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	43087000	USD
CY2011Q3	us-gaap	Stock Issued During Period Shares Treasury Stock Reissued StockIssuedDuringPeriodSharesTreasuryStockReissued	247600	shares
	us-gaap	Stock Issued During Period Shares Treasury Stock Reissued StockIssuedDuringPeriodSharesTreasuryStockReissued	2696300	shares
CY2012Q3	us-gaap	Stock Issued During Period Shares Treasury Stock Reissued StockIssuedDuringPeriodSharesTreasuryStockReissued	1200000	shares
	us-gaap	Stock Issued During Period Shares Treasury Stock Reissued StockIssuedDuringPeriodSharesTreasuryStockReissued	3400000	shares
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	15663000	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	14651000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	143945000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	104004000	USD
CY2012Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount	1100000000	USD
	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount	915000000	USD
CY2012Q3	us-gaap	Stockholders Equity StockholdersEquity	4171258000	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	3692872000	USD
CY2012Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4197581000	USD
CY2011Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3714999000	USD
CY2011Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3544964000	USD
CY2010Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4054125000	USD
CY2011Q4	us-gaap	Trading Account Assets Fair Value Disclosure TradingAccountAssetsFairValueDisclosure	46926000	USD
CY2012Q3	us-gaap	Trading Account Assets Fair Value Disclosure TradingAccountAssetsFairValueDisclosure	51025000	USD
CY2012Q3	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	60.12
	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	0
	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	58.57
CY2011Q3	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	47.79
CY2012Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	56345000	shares
CY2011Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	57187000	shares
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	16424000	shares
CY2012Q3	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	832000	shares
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	2561000	shares
CY2011Q4	us-gaap	Treasury Stock Value TreasuryStockValue	2912324000	USD
CY2012Q3	us-gaap	Treasury Stock Value TreasuryStockValue	2888603000	USD
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	149996000	USD
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	884995000	USD
CY2011Q3	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	50000000	USD
CY2012Q3	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	50000000	USD
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font></div></div>
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	160064000	shares
CY2012Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	160702000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	160519000	shares
CY2011Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	159002000	shares
CY2011Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	157816000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	158518000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	158971000	shares
CY2012Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	158783000	shares
CY2011Q4	dgx	Deferred Compensation Liabilities Fair Value Disclosure DeferredCompensationLiabilitiesFairValueDisclosure	71688000	USD
CY2012Q3	dgx	Deferred Compensation Liabilities Fair Value Disclosure DeferredCompensationLiabilitiesFairValueDisclosure	80259000	USD
	dgx	Earnings Allocated To Nonvested Share Based Payment Awards EarningsAllocatedToNonvestedShareBasedPaymentAwards	1934000	USD
CY2012Q3	dgx	Earnings Allocated To Nonvested Share Based Payment Awards EarningsAllocatedToNonvestedShareBasedPaymentAwards	663000	USD
	dgx	Earnings Allocated To Nonvested Share Based Payment Awards EarningsAllocatedToNonvestedShareBasedPaymentAwards	1989000	USD
CY2011Q3	dgx	Earnings Allocated To Nonvested Share Based Payment Awards EarningsAllocatedToNonvestedShareBasedPaymentAwards	967000	USD
CY2012Q3	dgx	Earnings Available To Companys Common Stockholders Basic And Diluted EarningsAvailableToCompanysCommonStockholdersBasicAndDiluted	162380000	USD
	dgx	Accounts Receivable AccountsReceivable	231375000	USD
	dgx	Accounts Receivable AccountsReceivable	271113000	USD
CY2011	dgx	Accumulated Net Gain Loss From Designated Or Qualifying Cash Flow Hedges AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedges	7700000	USD
	dgx	Accumulated Net Gain Loss From Designated Or Qualifying Cash Flow Hedges AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedges	7000000	USD
CY2011Q2	dgx	Agreement In Principle Amount Medi Cal Matter AgreementInPrincipleAmountMediCalMatter	241000000	USD
CY2011Q3	dgx	Assets Acquired Under Capital Lease AssetsAcquiredUnderCapitalLease	2927000	USD
CY2012Q3	dgx	Assets Acquired Under Capital Lease AssetsAcquiredUnderCapitalLease	1215000	USD
	dgx	Assets Acquired Under Capital Lease AssetsAcquiredUnderCapitalLease	4170000	USD
	dgx	Assets Acquired Under Capital Lease AssetsAcquiredUnderCapitalLease	5624000	USD
	dgx	Bank Guarantees BankGuarantees	1000000	USD
CY2011Q3	dgx	Cash Paid For Business Acquisitions CashPaidForBusinessAcquisitions	162138000	USD
	dgx	Cash Paid For Business Acquisitions CashPaidForBusinessAcquisitions	50574000	USD
	dgx	Cash Paid For Business Acquisitions CashPaidForBusinessAcquisitions	1410830000	USD
CY2012Q3	dgx	Cash Paid For Business Acquisitions CashPaidForBusinessAcquisitions	6000	USD
CY2012Q3	dgx	Debt Instrument Fair Value In Excess Of Carrying Value Of Debt DebtInstrumentFairValueInExcessOfCarryingValueOfDebt	521000000	USD
CY2011Q4	dgx	Debt Instrument Fair Value In Excess Of Carrying Value Of Debt DebtInstrumentFairValueInExcessOfCarryingValueOfDebt	387000000	USD
	dgx	Decrease Increase Related To Foreign Currency Translation DecreaseIncreaseRelatedToForeignCurrencyTranslation	13270000	USD
CY2011	dgx	Decrease Increase Related To Foreign Currency Translation DecreaseIncreaseRelatedToForeignCurrencyTranslation	-7260000	USD
CY2011Q3	dgx	Earnings Available To Companys Common Stockholders Basic And Diluted EarningsAvailableToCompanysCommonStockholdersBasicAndDiluted	171131000	USD
	dgx	Earnings Available To Companys Common Stockholders Basic And Diluted EarningsAvailableToCompanysCommonStockholdersBasicAndDiluted	280327000	USD
	dgx	Earnings Available To Companys Common Stockholders Basic And Diluted EarningsAvailableToCompanysCommonStockholdersBasicAndDiluted	497658000	USD
	dgx	Fair Value Of Net Assets Acquired FairValueOfNetAssetsAcquired	50531000	USD
	dgx	Fair Value Of Net Assets Acquired FairValueOfNetAssetsAcquired	1411981000	USD
CY2012Q3	dgx	Fair Value Of Net Assets Acquired FairValueOfNetAssetsAcquired	0	USD
CY2011Q3	dgx	Fair Value Of Net Assets Acquired FairValueOfNetAssetsAcquired	4729000	USD
	dgx	Finite Lived Intangible Assets Estimated Amortization Expense Total FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal	697920000	USD
CY2012Q3	dgx	Goodwill As Percentage Of Clinical Testing Business GoodwillAsPercentageOfClinicalTestingBusiness	0.90
CY2011Q4	dgx	Goodwill As Percentage Of Clinical Testing Business GoodwillAsPercentageOfClinicalTestingBusiness	0.9
CY2012Q3	dgx	Income From Continuing Operations Before Taxes IncomeFromContinuingOperationsBeforeTaxes	274839000	USD
CY2011Q3	dgx	Income From Continuing Operations Before Taxes IncomeFromContinuingOperationsBeforeTaxes	283269000	USD
	dgx	Income From Continuing Operations Before Taxes IncomeFromContinuingOperationsBeforeTaxes	843379000	USD
	dgx	Income From Continuing Operations Before Taxes IncomeFromContinuingOperationsBeforeTaxes	564003000	USD
CY2012Q3	dgx	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	1323431000	USD
CY2011Q4	dgx	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	1294857000	USD
	dgx	Interest Expense Net InterestExpenseNet	125303000	USD
CY2011Q3	dgx	Interest Expense Net InterestExpenseNet	43408000	USD
	dgx	Interest Expense Net InterestExpenseNet	127918000	USD
CY2012Q3	dgx	Interest Expense Net InterestExpenseNet	41028000	USD
	dgx	Merger Consideration Paid MergerConsiderationPaid	43000	USD
	dgx	Merger Consideration Paid MergerConsiderationPaid	-1151000	USD
CY2012Q3	dgx	Merger Consideration Paid MergerConsiderationPaid	6000	USD
CY2011Q3	dgx	Merger Consideration Paid MergerConsiderationPaid	157409000	USD
	dgx	Restructuring Charges And Integration Related Costs Adiditional Charges RestructuringChargesAndIntegrationRelatedCostsAdiditionalCharges	28800000	USD
	dgx	Schedule Of Derivative Instruments In Statement Of Financial Position Fair Value Disclosure Textblock ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueDisclosureTextblock	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A summary of the fair values of derivative instruments in the consolidated balance sheets is stated in the table below:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="43%" rowspan="1" colspan="1"></td><td width="19%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="19%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30, 2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2011</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance Sheet</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Classification</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance Sheet</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Classification</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Derivatives Designated as Hedging Instruments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asset Derivatives:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest rate swaps</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">870</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56,520</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liability Derivatives:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest rate swaps</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,148</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Derivatives Not Designated as Hedging Instruments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asset Derivatives:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">544</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">180</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liability Derivatives:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other current liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other current liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,648</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total Net Derivatives Asset</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">266</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55,052</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>
CY2011Q4	dgx	Original Dividend Payable Per Share OriginalDividendPayablePerShare	0.10
	dgx	Other Non Controlling Interests OtherNonControllingInterests	-2070000	USD
	dgx	Other Non Controlling Interests OtherNonControllingInterests	-1687000	USD
CY2012Q3	dgx	Other Operating Expense Net OtherOperatingExpenseNet	400000	USD
CY2011Q3	dgx	Other Operating Expense Net OtherOperatingExpenseNet	1781000	USD
	dgx	Other Operating Expense Net OtherOperatingExpenseNet	452000	USD
	dgx	Other Operating Expense Net OtherOperatingExpenseNet	238265000	USD
CY2011Q2	dgx	Payment For Medi Cal Matter PaymentForMediCalMatter	241000000	USD
	dgx	Percentage Of Net Revenues From Clinical Testing Business PercentageOfNetRevenuesFromClinicalTestingBusiness	0.9
CY2011Q3	dgx	Percentage Of Net Revenues From Clinical Testing Business PercentageOfNetRevenuesFromClinicalTestingBusiness	0.9
	dgx	Percentage Of Net Revenues From Clinical Testing Business PercentageOfNetRevenuesFromClinicalTestingBusiness	0.9
CY2012Q3	dgx	Percentage Of Net Revenues From Clinical Testing Business PercentageOfNetRevenuesFromClinicalTestingBusiness	0.9
CY2011Q1	dgx	Provision For Special Charge ProvisionForSpecialCharge	236000000	USD
	dgx	Provision For Special Charges ProvisionForSpecialCharges	0	USD
	dgx	Provision For Special Charges ProvisionForSpecialCharges	236000000	USD
	dgx	Restructuring Charges And Integration Related Costs RestructuringChargesAndIntegrationRelatedCosts	41382000	USD
CY2012Q3	dgx	Restructuring Charges And Integration Related Costs RestructuringChargesAndIntegrationRelatedCosts	34888000	USD
CY2012Q3	dgx	Restructuring Charges And Integration Related Costs Adiditional Charges RestructuringChargesAndIntegrationRelatedCostsAdiditionalCharges	9700000	USD
	dgx	Shares To Cover Employee Payroll Tax Withholdings On Stock Benefit Plans Value SharesToCoverEmployeePayrollTaxWithholdingsOnStockBenefitPlansValue	-19538000	USD
	dgx	Shares To Cover Employee Payroll Tax Withholdings On Stock Benefit Plans Value SharesToCoverEmployeePayrollTaxWithholdingsOnStockBenefitPlansValue	-19859000	USD
	dgx	Termination Of Interest Rate Swap Agreements TerminationOfInterestRateSwapAgreements	0	USD
	dgx	Termination Of Interest Rate Swap Agreements TerminationOfInterestRateSwapAgreements	71820000	USD
CY2012Q1	dgx	Treasury Stock Value Aquired Repurchase Program TreasuryStockValueAquiredRepurchaseProgram	1000000000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2012
	dei	Document Period End Date DocumentPeriodEndDate	2012-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001022079
CY2012Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	158967586	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	QUEST DIAGNOSTICS INC

Files In Submission

Name	View Source	Status
0001022079-12-000032-index-headers.html	Edgar Link	pending
0001022079-12-000032-index.html	Edgar Link	pending
0001022079-12-000032.txt	Edgar Link	pending
0001022079-12-000032-xbrl.zip	Edgar Link	pending
dgx-20120930.xml	Edgar Link	completed
dgx-20120930.xsd	Edgar Link	pending
dgx-20120930_cal.xml	Edgar Link	unprocessable
dgx-20120930_def.xml	Edgar Link	unprocessable
dgx-20120930_lab.xml	Edgar Link	unprocessable
dgx-20120930_pre.xml	Edgar Link	unprocessable
dgx0930201210-q.htm	Edgar Link	pending
dgx09302012ex31.htm	Edgar Link	pending
dgx09302012ex311.htm	Edgar Link	pending
dgx09302012ex312.htm	Edgar Link	pending
dgx09302012ex321.htm	Edgar Link	pending
dgx09302012ex322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DGX
QUEST DIAGNOSTICS INC Stock $dgx

2012 Q4 Form 10-Q Financial Statement

#000102207912000032 Filed on October 24, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DGX QUEST DIAGNOSTICS INC Stock $dgx

2012 Q4 Form 10-Q Financial Statement

#000102207912000032 Filed on October 24, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DGX
QUEST DIAGNOSTICS INC Stock $dgx